Confronting a killer
Defeating tuberculosis (TB) will require in-depth collaboration, including researchers, medical professionals but also the communities...
Suboptimal, inconsistent treatment for anaphylaxis due to unknown cause
A new Canadian study, led by a team at the Research Institute of the McGill University Health Centre (RI-MUHC), is shedding light on...
Another Medical Cold Case Cracked by the MUHC’s ‘Dr. House’
A team from the Research Institute of the McGill University Health Centre (RI-MUHC) led by Dr. Donald Vinh, the RI-MUHC’s so-called...
Can a smart app encourage HIV-self testing in Canada?
HIV self-testing strategies have been recommended by the World Health Organization (WHO) since 2016, as they empower people to find out...
Three RI-MUHC members named in the first-ever List of Canadian women leaders in global health
On November 20, the Canadian Society for International Health released its first Canadian...
Dr. Emily G. McDonald honoured by the Women’s Y Foundation
During an event held at the Écomusée du Fier Monde on October 25, the Women’s Y Foundation honoured Dr. Emily G. McDonald...
Madhukar Pai invited to first-ever UN High Level Meeting on Tuberculosis
Dr. Madhukar Pai, Director of McGill's International Tuberculosis Centre, Director of McGill Global Health Programs and a scientist at the...
High-dose flu vaccine improves immune response in rheumatoid arthritis
“People living with rheumatoid arthritis (RA) have an increased risk for influenza infection and influenza-related illness,” as Inès Colmegna...
The Journey of a USBJI Young Investigator in Research
In the September edition of the United States Bone and Joint Initiative (USBJI) Newsletter, Sasha Bernatsky, MD, PhD, FRCPC...
Life-saving epinephrine underused during anaphylaxis outside of hospital, study finds
Fewer than half of adults and children experiencing food-induced anaphylaxis use their epinephrine autoinjector (EAI) before being...